Diabetic Cardiomyopathy: 2023 Update by the International Multidisciplinary Board of Experts Ashot Avagimyan, Federica Fogacci, Nana Pogosova, Lev Kakrurskiy, Eugenia Kogan, Olga Urazova, Zhanna Kobalava, Liudmila Mikhaleva, Rositsa Vandysheva, Gioeva Zarina, Artem Trofimenko, Grizelda Navasardyan, Lusine Mkrtchyan, Mattia Galli, Zinaida Jndoyan, Current Problems in Cardiology.2024; 49(1): 102052. CrossRef
Cost-Effectiveness of New Quadruple Therapy Compared With Standard Treatment for Patients With Heart Failure in China Yun Huang, Hua Zhou, Chongbo Fang, Lili Ma, Yuyu Zhang, Weibo Rong, Xiaoli Liu, Honghua Ye Journal of Cardiovascular Pharmacology.2024; 83(1): 86. CrossRef
Evaluation of newly-developed glycated hemoglobin clinical analytic reagents and chromatography column on Tosoh HLC-723 G8 Analyzer Bo Yuan, Wei Yang, Na Zhang, Hongyan Shi, Shuangpeng Dong Practical Laboratory Medicine.2023; 37: e00338. CrossRef
Defining the Phenotypes for Heart Failure With Preserved Ejection Fraction Dane Rucker, Jacob Joseph Current Heart Failure Reports.2022; 19(6): 445. CrossRef
The cardiovascular disease continuum begins with risk factors such as diabetes mellitus (DM), progresses to vasculopathy and myocardial dysfunction, and finally ends with cardiovascular death. Diabetes is associated with a 2- to 4-fold increased risk for heart failure (HF). Moreover, HF patients with DM have a worse prognosis than those without DM. Diabetes can cause myocardial ischemia via micro- and macrovasculopathy and can directly exert deleterious effects on the myocardium. Hyperglycemia, hyperinsulinemia, and insulin resistance can cause alterations in vascular homeostasis. Then, reduced nitric oxide and increased reactive oxygen species levels favor inflammation leading to atherothrombotic progression and myocardial dysfunction. The classification, diagnosis, and treatment of HF for a patient with and without DM remain the same. Until now, drugs targeting neurohumoral and metabolic pathways improved mortality and morbidity in HF with reduced ejection fraction (HFrEF). Therefore, all HFrEF patients should receive guideline-directed medical therapy. By contrast, drugs modulating neurohumoral activity did not improve survival in HF with preserved ejection fraction (HFpEF) patients. Trials investigating whether sodium-glucose cotransporter-2 inhibitors are effective in HFpEF are on-going. This review will summarize the epidemiology, pathophysiology, and treatment of HF in diabetes.
Citations
Citations to this article as recorded by
Efficacy of Platelet-Rich Plasma in the Treatment of Diabetic Foot Ulcers: A Systematic Review and Meta-Analysis Yundong Peng, JiePing Wang, Xinyao Liu, Yanqing Zhou, Shaohui Jia, Jinrong Xu, Cheng Zheng Annals of Vascular Surgery.2024; 98: 365. CrossRef
Diabetic Cardiomyopathy: 2023 Update by the International Multidisciplinary Board of Experts Ashot Avagimyan, Federica Fogacci, Nana Pogosova, Lev Kakrurskiy, Eugenia Kogan, Olga Urazova, Zhanna Kobalava, Liudmila Mikhaleva, Rositsa Vandysheva, Gioeva Zarina, Artem Trofimenko, Grizelda Navasardyan, Lusine Mkrtchyan, Mattia Galli, Zinaida Jndoyan, Current Problems in Cardiology.2024; 49(1): 102052. CrossRef
Emerging Biomarkers in the Laboratory and in Practice: A Novel Approach to Diagnosing Heart Failure in Diabetes Rachel E. Aaron, Tiffany Tian, G. Alexander Fleming, David B. Sacks, James L. Januzzi, Rodica Pop-Busui, Ibrahim A. Hashim, Alan H. B. Wu, Ambarish Pandey, David C. Klonoff Journal of Diabetes Science and Technology.2024;[Epub] CrossRef
Research Progress on the Relationship between HbA1c and Diabetes Complicated with Chronic Heart Failure ·依沙 迪达尔 Advances in Clinical Medicine.2024; 14(01): 1117. CrossRef
Association Between Use of Sodium-Glucose Cotransporter-2 Inhibitors or Angiotensin Receptor-Neprilysin Inhibitor and the Risk of Atherosclerotic Cardiovascular Disease With Coexisting Diabetes and Heart Failure Ya-Wen Lin, Chun-Hsiang Lin, Cheng-Li Lin, Che-Huei Lin, Ming-Hung Lin Journal of Cardiovascular Pharmacology and Therapeutics.2024;[Epub] CrossRef
The Role of Epicardial Adipose Tissue in Acute Coronary Syndromes, Post-Infarct Remodeling and Cardiac Regeneration Kamil Krauz, Marcel Kempiński, Paweł Jańczak, Karol Momot, Maciej Zarębiński, Izabela Poprawa, Małgorzata Wojciechowska International Journal of Molecular Sciences.2024; 25(7): 3583. CrossRef
Molecular mechanisms of metabolic dysregulation in diabetic cardiomyopathy Yue Zeng, Yilang Li, Wenyue Jiang, Ning Hou Frontiers in Cardiovascular Medicine.2024;[Epub] CrossRef
Association between nonalcoholic fatty liver disease and left ventricular diastolic dysfunction: A 7-year retrospective cohort study of 3,496 adults using serial echocardiography Gyuri Kim, Tae Yang Yu, Jae Hwan Jee, Ji Cheol Bae, Mira Kang, Jae Hyeon Kim Diabetes & Metabolism.2024; : 101534. CrossRef
SGLT2 Inhibitors in the Cardiovascular Disease Jin Joo Park The Journal of Korean Diabetes.2024; 25(1): 26. CrossRef
Metabolic Alteration Bridging the Prediabetic State and Colorectal Cancer Antonino Colloca, Isabella Donisi, Camilla Anastasio, Maria Luisa Balestrieri, Nunzia D’Onofrio Cells.2024; 13(8): 663. CrossRef
Inflammation in diabetes complications: molecular mechanisms and therapeutic interventions Lu Zhao, Haoran Hu, Lin Zhang, Zheting Liu, Yunchao Huang, Qian Liu, Liang Jin, Meifei Zhu, Ling Zhang MedComm.2024;[Epub] CrossRef
Methods to predict heart failure in diabetes patients Alexander E. Berezin, Tetiana A Berezina, Uta C. Hoppe, Michael Lichtenauer, Alexander A. Berezin Expert Review of Endocrinology & Metabolism.2024; : 1. CrossRef
Association between Dapagliflozin, Cardiac Biomarkers and Cardiac Remodeling in Patients with Diabetes Mellitus and Heart Failure Andrew Xanthopoulos, Nikolaos Katsiadas, Spyridon Skoularigkis, Dimitrios E. Magouliotis, Niki Skopeliti, Sotirios Patsilinakos, Alexandros Briasoulis, Filippos Triposkiadis, John Skoularigis Life.2023; 13(8): 1778. CrossRef
Empagliflozin for Patients with Heart Failure and Type 2 Diabetes Mellitus: Clinical Evidence in Comparison with Other Sodium-Glucose Co-transporter-2 Inhibitors and Potential Mechanism Bo Liang, Rui Li, Peng Zhang, Ning Gu Journal of Cardiovascular Translational Research.2023; 16(2): 327. CrossRef
Causes and Determinants of Heart Failure Readmissions Post Transcutaneous Aortic Valve Replacement: A Systematic Review and Meta-Analysis Farah Yasmin, Muhammad Aamir, Abdul Moeed, Kinza Iqbal, Aymen Iqbal, Muhammad Sohaib Asghar, Waqas Ullah, Indranee Rajapreyar, Yevgeniy Brailovsky Current Problems in Cardiology.2023; 48(1): 101428. CrossRef
Discussion of a study on the role of EMS in prognosis of elderly patients with AHF Qingzhuo Yang, Hui Wu, Di Liu, Yunzhao Li, Gang Zhou, Dong Zhang, Yanfang Liu, Yi Li International Journal of Cardiology.2023; 377: 91. CrossRef
The management correlation between metabolic index, cardiovascular health, and diabetes combined with cardiovascular disease Yi Zhang, Chao Liu, Yijing Xu, Yanlei Wang, Fang Dai, Honglin Hu, Tian Jiang, Yunxia Lu, Qiu Zhang Frontiers in Endocrinology.2023;[Epub] CrossRef
Evaluation and Management of Patients With Diabetes and Heart Failure: A Korean Diabetes Association and Korean Society of Heart Failure Consensus Statement Kyu-Sun Lee, Junghyun Noh, Seong-Mi Park, Kyung Mook Choi, Seok-Min Kang, Kyu-Chang Won, Hyun-Jai Cho, Min Kyong Moon International Journal of Heart Failure.2023; 5(1): 1. CrossRef
Evaluation and Management of Patients with Diabetes and Heart Failure: A Korean Diabetes Association and Korean Society of Heart Failure Consensus Statement Kyu-Sun Lee, Junghyun Noh, Seong-Mi Park, Kyung Mook Choi, Seok-Min Kang, Kyu-Chang Won, Hyun-Jai Cho, Min Kyong Moon Diabetes & Metabolism Journal.2023; 47(1): 10. CrossRef
Lower Circulating Cell-Free Mitochondrial DNA Is Associated with Heart Failure in Type 2 Diabetes Mellitus Patients Tetiana A. Berezina, Mykola P. Kopytsya, Olga V. Petyunina, Alexander A. Berezin, Zeljko Obradovic, Lukas Schmidbauer, Michael Lichtenauer, Alexander E. Berezin Cardiogenetics.2023; 13(1): 15. CrossRef
Novel model predicts diastolic cardiac dysfunction in type 2 diabetes Mingyu Hao, Xiaohong Huang, Xueting Liu, Xiaokang Fang, Haiyan Li, Lingbo Lv, Liming Zhou, Tiecheng Guo, Dewen Yan Annals of Medicine.2023; 55(1): 766. CrossRef
Cholinergic drugs reduce metabolic inflammation and diabetic myocardial injury by regulating the gut bacterial component lipopolysaccharide‐induced ERK/Egr‐1 pathway Qing Wu, Ming Zhao, Dongling Li, Xi He, Weijin Zang The FASEB Journal.2023;[Epub] CrossRef
Ferroptosis: roles and molecular mechanisms in diabetic cardiomyopathy Yangting Zhao, Binjing Pan, Xiaoyu Lv, Chongyang Chen, Kai Li, Yawen Wang, Jingfang Liu Frontiers in Endocrinology.2023;[Epub] CrossRef
Cardiorenal syndrome and diabetes: an evil pairing Ana Belén Méndez Fernández, Ander Vergara Arana, Aleix Olivella San Emeterio, Maria Antonieta Azancot Rivero, Toni Soriano Colome, Maria Jose Soler Romeo Frontiers in Cardiovascular Medicine.2023;[Epub] CrossRef
Therapeutic Potential of Hibiscus sabdariffa Linn. in Attenuating Cardiovascular Risk Factors Syaifuzah Sapian, Asma Ali Ibrahim Mze, Fatin Farhana Jubaidi, Nor Anizah Mohd Nor, Izatus Shima Taib, Zariyantey Abd Hamid, Satirah Zainalabidin, Nur Najmi Mohamad Anuar, Haliza Katas, Jalifah Latip, Juriyati Jalil, Nur Faizah Abu Bakar, Siti Balkis Budi Pharmaceuticals.2023; 16(6): 807. CrossRef
Exploring the prospect of intrinsic wave propagation in evaluating myocardial stiffness among patients with type 2 diabetes Qiao Cheng, Xiao Huang, Xinying Fan, Jie Sun, Jun Zhang, Qiaoying Tang, Youbin Deng, Xiaojun Bi Frontiers in Cardiovascular Medicine.2023;[Epub] CrossRef
The multidimensional prognostic index (MPI) predicts long-term mortality in old type 2 diabetes mellitus patients: a 13-year follow-up study F. Salis, E. Cossu, A. Mandas Journal of Endocrinological Investigation.2023; 47(1): 191. CrossRef
PRDM16 exerts critical role in myocardial metabolism and energetics in type 2 diabetes induced cardiomyopathy Tongtong Hu, Qingqing Wu, Qi Yao, Jiabin Yu, Kebing Jiang, Ying Wan, Qizhu Tang Metabolism.2023; 146: 155658. CrossRef
Empagliflozin Reduces Interleukin-6 Levels in Patients with Heart Failure Michael Gotzmann, Pauline Henk, Ulrik Stervbo, Arturo Blázquez-Navarro, Andreas Mügge, Nina Babel, Timm H. Westhoff Journal of Clinical Medicine.2023; 12(13): 4458. CrossRef
Features of the course and complications of acute myocardial infarction in type 2 diabetes mellitus M. N. Zatsepina, F. O. Ushanova, T. L. Bogacheva FOCUS. Endocrinology.2023; 4(2): 42. CrossRef
Admission triglyceride-glucose index is predictor of long-term mortality and appropriate implantable cardiac defibrillator therapy in patients with heart failure Kazım S Özcan, Mert İ Hayıroğlu, Tufan Çınar Biomarkers in Medicine.2023; 17(10): 487. CrossRef
Emerging Roles of Phospholipase C Beta Isozymes as Potential Biomarkers in Cardiac Disorders Antonietta Fazio, Camilla Evangelisti, Alessandra Cappellini, Sara Mongiorgi, Foteini-Dionysia Koufi, Irene Neri, Maria Vittoria Marvi, Michele Russo, Alessandra Ghigo, Lucia Manzoli, Roberta Fiume, Stefano Ratti International Journal of Molecular Sciences.2023; 24(17): 13096. CrossRef
Research progress of dihydromyricetin in the treatment of diabetes mellitus Ziyuan Wang, Zhuoran Cao, Zhiying Yue, Zhengfeng Yang Frontiers in Endocrinology.2023;[Epub] CrossRef
Assessment of subclinical left ventricular myocardial systolic dysfunction in type 2 diabetes mellitus patients with or without hypertension by global and segmental myocardial work Guang-An Li, Jun Huang, Xiao Sheng, Li Fan Diabetology & Metabolic Syndrome.2023;[Epub] CrossRef
Managing heart failure in diabetics with dual acting sotagliflozin—A review Kushal Seni, Pooja A Chawla Health Sciences Review.2023; 9: 100130. CrossRef
Association between triglyceride glucose-body mass index and heart failure in subjects with diabetes mellitus or prediabetes mellitus: a cross-sectional study Shuping Yang, Xiangxiang Shi, Wanlu Liu, Zhaokai Wang, Ruoshui Li, Xianzhi Xu, Chaofan Wang, Lei Li, Ruili Wang, Tongda Xu Frontiers in Endocrinology.2023;[Epub] CrossRef
Influence of Sociodemographic Variables and Healthy Habits on the Values of Insulin Resistance Indicators in 386,924 Spanish Workers Miguel Mestre Font, Carla Busquets-Cortés, José Ignacio Ramírez-Manent, Pilar Tomás-Gil, Hernán Paublini, Ángel Arturo López-González Nutrients.2023; 15(24): 5122. CrossRef
The effect of dapagliflozin on ventricular arrhythmias, cardiac arrest, or sudden death in people with heart failure: a tick in another box for sodium-glucose cotransporter 2 inhibitors Theocharis Koufakis, George Giannakoulas, Pantelis Zebekakis, Kalliopi Kotsa Expert Opinion on Pharmacotherapy.2022; 23(3): 321. CrossRef
The peculiar role of vitamin D in the pathophysiology of cardiovascular and neurodegenerative diseases Milijana Janjusevic, Giulia Gagno, Alessandra Lucia Fluca, Laura Padoan, Antonio Paolo Beltrami, Gianfranco Sinagra, Rita Moretti, Aneta Aleksova Life Sciences.2022; 289: 120193. CrossRef
Mechanisms of cardiac dysfunction in diabetic cardiomyopathy: molecular abnormalities and phenotypical variants Francesca Romana Prandi, Isabella Evangelista, Domenico Sergi, Alberto Palazzuoli, Francesco Romeo Heart Failure Reviews.2022; 28(3): 597. CrossRef
Modern Approaches to Treatment of Chronic Heart Failure in Patients with Type 2 Diabetes Mellitus Yu. G. Gorb, S. A. Serik, O. V. Tkachenko, V. V. Ryabukha Ukraïnsʹkij žurnal medicini, bìologìï ta sportu.2022; 7(1): 14. CrossRef
Metabonomic Characteristics of Myocardial Diastolic Dysfunction in Type 2 Diabetic Cardiomyopathy Patients Mingyu Hao, Jianxin Deng, Xiaohong Huang, Haiyan Li, Huiting Ou, Xiangsheng Cai, Jiajie She, Xueting Liu, Ling Chen, Shujuan Chen, Wenlan Liu, Dewen Yan Frontiers in Physiology.2022;[Epub] CrossRef
Serum Levels of Irisin Predict Cumulative Clinical Outcomes in Heart Failure Patients With Type 2 Diabetes Mellitus Alexander A. Berezin, Michael Lichtenauer, Elke Boxhammer, Ivan M. Fushtey, Alexander E. Berezin Frontiers in Physiology.2022;[Epub] CrossRef
Heart Failure: An Underappreciated Complication of Diabetes. A Consensus Report of the American Diabetes Association Rodica Pop-Busui, James L. Januzzi, Dennis Bruemmer, Sonia Butalia, Jennifer B. Green, William B. Horton, Colette Knight, Moshe Levi, Neda Rasouli, Caroline R. Richardson Diabetes Care.2022; 45(7): 1670. CrossRef
Von Willebrand factor (vWF) in patients with heart failure with preserved ejection fraction (HFpEF): A retrospective observational study Mayila Abudoukelimu, Bayinsilema Ba, Yan Kai Guo, Jie Xu Medicine.2022; 101(31): e29854. CrossRef
Why Does the Intravenous Iron Supplementation Not Work in Heart Failure Patients on Hemodialysis? Jin Joo Park CardioMetabolic Syndrome Journal.2022; 2(2): 176. CrossRef
Severe hypoglycemia and risk of hospitalization for heart failure in adults with diabetes treated with oral medications with or without insulin: A population-based study You-Bin Lee, Yoon-Jong Bae, Hoseob Kim, Jiyun Park, So Yoon Kwon, So Hee Park, Gyuri Kim, Kyu Yeon Hur, Jae Hyeon Kim, Sang-Man Jin Diabetes Research and Clinical Practice.2022; 192: 110083. CrossRef
Blood Pressure Target in Type 2 Diabetes Mellitus Hyun-Jin Kim, Kwang-il Kim Diabetes & Metabolism Journal.2022; 46(5): 667. CrossRef
Application Value of Systemic Inflammatory Indexes in the Clinical Evaluation of Patients with Heart Failure with Preserved Ejection Fraction (HFpEF) Ruxin Wang, Juan Wu, Haowen Ye, Xiaofang Zhang, Lihong Wang Medicina.2022; 58(10): 1473. CrossRef
HFpEF and Atrial Fibrillation: The Enigmatic Interplay of Dysmetabolism, Biomarkers, and Vascular Endothelial Dysfunction Jure Bosanac, Lara Straus, Marko Novaković, Daniel Košuta, Mojca Božič Mijovski, Jerneja Tasič, Borut Jug, Azizah Ugusman Disease Markers.2022; 2022: 1. CrossRef
The importance of caveolin as a target in the prevention and treatment of diabetic cardiomyopathy Weiyi Xia, Xia Li, Qingping Wu, Aimin Xu, Liangqing Zhang, Zhengyuan Xia Frontiers in Immunology.2022;[Epub] CrossRef
Microvascular Burden and Incident Heart Failure Among Middle-Aged and Older Adults With Type 1 or Type 2 Diabetes Fu-Rong Li, Daniel Nyarko Hukportie, Jing Yang, Huan-Huan Yang, Guo-Chong Chen, Xian-Bo Wu Diabetes Care.2022; 45(12): 2999. CrossRef
C-reactive protein and statins in heart failure with reduced and preserved ejection fraction Jin Joo Park, Minjae Yoon, Hyoung-Won Cho, Hyun-Jai Cho, Kye Hun Kim, Dong Heon Yang, Byung-Su Yoo, Seok-Min Kang, Sang Hong Baek, Eun-Seok Jeon, Jae-Joong Kim, Myeong-Chan Cho, Shung Chull Chae, Byung-Hee Oh, Dong-Ju Choi Frontiers in Cardiovascular Medicine.2022;[Epub] CrossRef
Pharmacological treatment of type 2 diabetes in elderly patients with heart failure: randomized trials and beyond Angela Sciacqua, Elena Succurro, Giuseppe Armentaro, Sofia Miceli, Daniele Pastori, Giuseppe Rengo, Giorgio Sesti Heart Failure Reviews.2021; 28(3): 667. CrossRef